YK5, a novel dual Hsc70 and Hsp70 inhibitor, is selective for tumor Hsp70 and has potent but selective activity in cancer cells Meeting Abstract


Authors: Rodina, A.; Kang, Y.; Maharaj, R.; Gozman, A.; Taldone, T.; Cerchietti, L.; Wong, M. J. H.; Baaklini, I.; Caldas-Lopes, E.; Clement, C. C.; Brodsky, J.; Erdjument-Bromage, H.; Ma, Y.; Melnick, A.; Young, J. C.; Chiosis, G.
Abstract Title: YK5, a novel dual Hsc70 and Hsp70 inhibitor, is selective for tumor Hsp70 and has potent but selective activity in cancer cells
Meeting Title: 101st Annual Meeting of the American Association for Cancer Research (AACR)
Keywords: biochemistry and molecular biophysics; tumor biology; tumorigenesis; pharmacology; disease prognosis; cellular transformation; pharmacologic interference; pathogenic
Journal Title: Cancer Research
Volume: 70
Issue: 8 Suppl.
Meeting Dates: 2010 Apr 17-21
Meeting Location: Washington, DC
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2010-04-15
Start Page: 1325
Language: English
ACCESSION: BIOSIS:PREV201000526323
PROVIDER: biosis
DOI: 10.1158/1538-7445.AM10-5463
Notes: --- - Meeting Abstract 5463 - In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research - Washington, DC, USA - April 17 -21, 2010 - Amer Assoc Canc Res - "Source: Biosis"
Altmetric
Citation Impact
BMJ Impact Analytics